Skip to main content
logo
Ilyang Pharmaceutical Co.,Ltd (KRX:007570)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,070.00
-200.00 (-2.42%)
Sep 11, 2026, 3:30 PM KST

KRX:007570 Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
277,956272,422268,678266,669247,773242,511
Revenue Growth
0.65%1.39%0.75%7.63%2.17%-29.37%
Gross Profit
109,845116,280111,217116,404108,194104,646
Operating Income
-13,7274,9639,62216,37914,24915,188
Net Income
16,8416,7279,032-2,32118,93314,032
Earnings Per Share
968.50374.81490.00-131.001044.53770.78
EPS Growth
74.06%-23.51%--35.52%29.11%

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
17,73829,62712,79013,69012,59343,631
Total Debt
103,670126,794107,68172,65074,10398,503
Net Cash (Debt)
-85,932-97,168-94,891-58,960-61,511-54,872
Net Cash Growth
------
Net Cash Per Share
-4941.86-5414.14-5148.09-3272.13-3393.60-3014.10

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
34,48912,0415,61514,6195,88351,429
Capital Expenditures
-6,162-5,717-38,200-5,883-3,946-12,371
Free Cash Flow
28,3266,323-32,5858,7361,93839,057
Free Cash Flow Growth
---350.88%-95.04%-17.44%

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
39.52%42.68%41.39%43.65%43.67%43.15%
Operating Margin
-4.94%1.82%3.58%6.14%5.75%6.26%
Pretax Margin
8.12%4.87%4.06%-0.67%9.62%9.10%
Profit Margin
6.06%2.47%3.36%-0.87%7.64%5.79%
FCF Margin
10.19%2.32%-12.13%3.28%0.78%16.11%

Dividends
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingSep '26 Dec '25 Dec '24 Dec '23
Dividend Per Share
155.000--150.000
Dividend Per Share Growth
3.33%---
Dividend Yield
1.83%--0.98%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
8.3334.7722.76-18.4936.39
Forward PE
-49.9049.9049.9049.9049.90
P/FCF Ratio
5.1136.99-32.19180.6213.07
PS Ratio
0.520.860.771.061.412.11